Systemic Protein Delivery via Inhalable Liposomes: Formulation and Pharmacokinetics
The enormous and thin alveolar epithelium is an attractive site for systemic protein delivery. Considering the excellent biocompatibility of phospholipids with endogenous pulmonary surfactant, we engineered dimyristoylphosphatidylcholine (DMPC)-based liposomes for pulmonary administration, using Cy5...
Main Authors: | Pranav Ponkshe, Yingzhe Wang, Chalet Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/7/1951 |
Similar Items
-
Enhanced Pharmacokinetics of Celastrol via Long-Circulating Liposomal Delivery for Intravenous Administration
by: Wang B, et al.
Published: (2024-06-01) -
Aerosol Inhalation Delivery of Ag Nanoparticles in Mice: Pharmacokinetics and Antibacterial Action
by: Sergey V. Valiulin, et al.
Published: (2023-10-01) -
Liposomal Forms of Fluoroquinolones and Antifibrotics Decorated with Mannosylated Chitosan for Inhalation Drug Delivery
by: Irina Le-Deygen, et al.
Published: (2023-03-01) -
Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases
by: Yiheng Huang, et al.
Published: (2024-07-01) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
by: Jiani Yuan, et al.
Published: (2017-11-01)